Response rate according to Response Evaluation Criteria in Solid Tumours ( RECIST ) v. 1.0 was significantly higher in DXCT arm ( 27.0 % versus 5.9 % ) , but response according to Choi criteria showed fewer differences between treatment arms ( 45.9 % versus 37.3 % ) .